U.S. markets close in 2 minutes
  • S&P 500

    3,370.48
    +35.01 (+1.05%)
     
  • Dow 30

    27,845.39
    +392.73 (+1.43%)
     
  • Nasdaq

    11,192.34
    +107.09 (+0.97%)
     
  • Russell 2000

    1,504.25
    -0.48 (-0.03%)
     
  • Crude Oil

    40.01
    +0.72 (+1.83%)
     
  • Gold

    1,893.00
    -10.20 (-0.54%)
     
  • Silver

    23.41
    -1.03 (-4.23%)
     
  • EUR/USD

    1.1730
    -0.0015 (-0.13%)
     
  • 10-Yr Bond

    0.6770
    +0.0320 (+4.96%)
     
  • GBP/USD

    1.2912
    +0.0052 (+0.41%)
     
  • USD/JPY

    105.4400
    -0.2150 (-0.20%)
     
  • BTC-USD

    10,738.54
    -105.67 (-0.97%)
     
  • CMC Crypto 200

    221.24
    -0.15 (-0.07%)
     
  • FTSE 100

    5,866.10
    -31.40 (-0.53%)
     
  • Nikkei 225

    23,185.12
    -353.98 (-1.50%)
     

Illumina to Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

UBS Genomics 2.0 and MedTech Innovations Virtual Summit
Wednesday, August 12, 2020 at 10:00am Pacific Time

The live webcasts can be accessed in the Investor Info section of Illumina's web site under the "company" tab at www.illumina.com. A replay of the presentations will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200807005088/en/

Contacts

Investors:
Jacquie Ross, CFA
+1.858.882.2172
ir@illumina.com

Media:
Dr. Karen Birmingham
+44.7500.105665
kbirmingham@illumina.com